Are persons with asthma at increased risk of pneumococcal infections, and can we prevent them?

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 4, 2008, Pages 724-725

  Hartert, Tina V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; infection; pneumococcal disease; pneumococcal vaccine

Indexed keywords

ANTIASTHMATIC AGENT; PNEUMOCOCCUS VACCINE;

ASTHMA; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; DRUG EFFICACY; EDITORIAL; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LOBAR PNEUMONIA; MORBIDITY; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; ASTHMA; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 53249119636     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.09.008     Document Type: Editorial

References (15)

1. Juhn Y.J., Kita H., Yawn B.P., Boyce T.G., Yoo K.H., McGree M.E., et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 122 (2008) 719-723
2. Talbot T.R., Hartert T.V., Mitchel E., Halasa N.B., Arbogast P.G., Poehling K.A., et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 352 (2005) 2082-2090
3. Almirall J., Bolibar I., Serra-Prat M., Roig J., Hospital I., Carandell E., et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 31 (2008) 1274-1284
4. Hammad H., and Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 8 (2008) 193-204
5. Schleimer R.P., Kato A., Kern R., Kuperman D., and Avila P.C. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 120 (2007) 1279-1284
6. Xatzipsalti M., Kyrana S., Tsolia M., Psarras S., Bossios A., Laza-Stanca V., et al. Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med 172 (2005) 1037-1040
7. Johnston S.L. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc Am Thorac Soc 4 (2007) 267-270
8. Holt P.G., Upham J.W., and Sly P.D. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 116 (2005) 16-24
9. Bisgaard H., Hermansen M.N., Buchvald F., Loland L., Halkjaer L.B., Bonnelykke K., et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357 (2007) 1487-1495
10. Cardozo D.M., Nascimento-Carvalho C.M., Andrade A.L., Silvany-Neto A.M., Daltro C.H., Brandao M.A., et al. Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents. J Med Microbiol 57 (2008) 185-189
11. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351 (1998) 1225-1232
12. Moorman J.E., Rudd R.A., Johnson C.A., King M., Minor P., Bailey C., et al. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 56 (2007) 1-54
13. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49 RR-9 (2000) 1-35
14. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46 RR-8 (1997) 1-24
15. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel report 3: guidelines for the diagnosis and management of asthma. Full report 2007 (2007), US Department of Health and Human Services, National Institutes of Health, Bethesda (MD) NIH publication no. 07-4051